Transcatheter Aortic Valve Replacement (TAVR) serves as a critical, minimally invasive alternative to traditional surgical aortic valve replacement for patients with severe aortic stenosis. Dr. Clint Tippett, a cardiac anesthesiologist, details the evolution of TAVR from a high-risk, general-anesthesia-dependent procedure to a more routine intervention often performed under monitored anesthesia care. Key clinical considerations include the assessment of patient risk profiles, the management of hemodynamic stability during rapid ventricular pacing, and the mitigation of complications like coronary occlusion or heart block. While traditional surgical valve replacement remains the gold standard for low-risk patients, emerging data and technological advancements suggest a shift toward TAVR, potentially enabling same-day discharges and valve-in-valve procedures for younger populations. As procedural experience grows, the reliance on intensive monitoring and standby surgical support continues to decrease, signaling a broader adoption of this technology across diverse healthcare settings.
Sign in to continue reading, translating and more.
Continue